Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review
Abstract Investigating novel biomarkers discriminating thyroid nodules is a matter of great importance for differential diagnosis. The current study was planned to investigate the diagnostic value of fibulin-1 in plasma specimens of patients with thyroid nodules. A literature review was also performed to gain an understanding of the existing research relevant to the main role of fibulin-1 in carcinogenesis. In this case-control study, the levels of plasma fibulin-1 were compared in 82 subjects including papillary thyroid cancer (PTC; n = 30), multinodular goiter (MNG; n = 30), and healthy subjects (n = 22) using enzyme-linked immunosorbent assay (ELISA). Fibulin-1 levels of patients with PTC and MNG were documented to be significantly lower than those of healthy subjects (PTC vs. Healthy; P = 0.000, MNG vs. Healthy; P = 0.000). No statistically significant differences were found between PTC and MNG groups when fibulin-1 levels were compared (P > 0.05). Low level of plasma fibulin-1 was associated with an increased risk of PTC tumorigenesis (odds ratio = 0.810; 95% CI: 0.704–0.933; P = 0.003). Further, fibulin-1 had an appropriate diagnostic value for detecting PTC patients with a sensitivity of 73.33%, and specificity of 100% at the cutoff value > 4.9 (ng/ml). According to the results of the present research which are tied well with previous studies, the abnormal downregulation of fibulin-1 may play a role in the PTC and MNG tumorigenesis. In addition, fibulin-1 probably promotes the development and progression of other human cancer; however, further studies are needed to improve current understandings..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Molecular biology reports - 47(2020), 11 vom: 26. Okt., Seite 8859-8866 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hedayati, Mehdi [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Extracellular matrix |
Anmerkungen: |
© Springer Nature B.V. 2020 |
---|
doi: |
10.1007/s11033-020-05938-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2121313257 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2121313257 | ||
003 | DE-627 | ||
005 | 20230504183545.0 | ||
007 | tu | ||
008 | 230504s2020 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s11033-020-05938-x |2 doi | |
035 | |a (DE-627)OLC2121313257 | ||
035 | |a (DE-He213)s11033-020-05938-x-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |q VZ |
084 | |a 12 |2 ssgn | ||
084 | |a BIODIV |q DE-30 |2 fid | ||
084 | |a 42.00 |2 bkl | ||
100 | 1 | |a Hedayati, Mehdi |e verfasserin |0 (orcid)0000-0001-5816-775X |4 aut | |
245 | 1 | 0 | |a Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer Nature B.V. 2020 | ||
520 | |a Abstract Investigating novel biomarkers discriminating thyroid nodules is a matter of great importance for differential diagnosis. The current study was planned to investigate the diagnostic value of fibulin-1 in plasma specimens of patients with thyroid nodules. A literature review was also performed to gain an understanding of the existing research relevant to the main role of fibulin-1 in carcinogenesis. In this case-control study, the levels of plasma fibulin-1 were compared in 82 subjects including papillary thyroid cancer (PTC; n = 30), multinodular goiter (MNG; n = 30), and healthy subjects (n = 22) using enzyme-linked immunosorbent assay (ELISA). Fibulin-1 levels of patients with PTC and MNG were documented to be significantly lower than those of healthy subjects (PTC vs. Healthy; P = 0.000, MNG vs. Healthy; P = 0.000). No statistically significant differences were found between PTC and MNG groups when fibulin-1 levels were compared (P > 0.05). Low level of plasma fibulin-1 was associated with an increased risk of PTC tumorigenesis (odds ratio = 0.810; 95% CI: 0.704–0.933; P = 0.003). Further, fibulin-1 had an appropriate diagnostic value for detecting PTC patients with a sensitivity of 73.33%, and specificity of 100% at the cutoff value > 4.9 (ng/ml). According to the results of the present research which are tied well with previous studies, the abnormal downregulation of fibulin-1 may play a role in the PTC and MNG tumorigenesis. In addition, fibulin-1 probably promotes the development and progression of other human cancer; however, further studies are needed to improve current understandings. | ||
650 | 4 | |a Papillary thyroid cancer | |
650 | 4 | |a Multinodular goiter | |
650 | 4 | |a Extracellular matrix | |
650 | 4 | |a Fibulin-1 | |
650 | 4 | |a gene | |
700 | 1 | |a Abooshahab, Raziyeh |4 aut | |
700 | 1 | |a Razavi, S. Adeleh |4 aut | |
700 | 1 | |a Salehipour, Pouya |4 aut | |
700 | 1 | |a Ahmadikia, Kazem |4 aut | |
700 | 1 | |a Boroomand, Seti |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular biology reports |d Springer Netherlands, 1960 |g 47(2020), 11 vom: 26. Okt., Seite 8859-8866 |w (DE-627)129400998 |w (DE-600)186544-4 |w (DE-576)014783312 |x 0301-4851 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2020 |g number:11 |g day:26 |g month:10 |g pages:8859-8866 |
856 | 4 | 1 | |u https://doi.org/10.1007/s11033-020-05938-x |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-CHE | ||
936 | b | k | |a 42.00 |q VZ |
951 | |a AR | ||
952 | |d 47 |j 2020 |e 11 |b 26 |c 10 |h 8859-8866 |